Publisert 26.02.2019

3D-bioprinting for wound healing- CellHeal AS collaboration

On February 26th 2019, Regenics AS and CellHeal AS signed a collaborative agreement "Main collaboration terms for the research and Research Project of 3D bio-printed patch incorporating HTX for wound healing". The project will attempt to bioprint a 3D patch with a marine reepitelialization agent.


Regenics is proud to announce its first collaboration within 3D-bioprinting with the Norwegian company CellHeal AS. Cell Heal is led by Paul Gatenholm. Gatenholm is a world leading expert on 3D-bioprinting and is professor at Chalmers , Gothenburg, Sweden and Director of 3D Bioprinting Center, BBV at Biotech Center. He is WWSC Graduate School Coordinator at the Department of Chemistry and Chemical Engineering, Biopolymer Technology. Paul also serves as Adjunct Professor at Virginia Tech and Wake Forest Institute for Regenerative Medicine, USA.

Regenics CEO Henrik Lund says: " We are very fortunate to be working with Paul Gatenholm with our wound healing technology Vernex. Initially the feasability of HTX in 3D-bioprinting will be explored".

Chief Scientific Officer Adam Robertsson and Researcher Markus Heldrup, will lead the project for Regenics. 

 
 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.